FDA Grants Orphan Drug Status for ACE-083 to Treat Muscular Dystrophy
Acceleron Phama develops innovative treatments to treat rare diseases like FSHD
Acceleron Pharma is a Cambridge-based company that focuses on developing treatments for rare conditions like FSHD. They also collaborate with partners around the world to find treatment for pateitn with chronic anemia, myeldysplastic syndrome, myelofibrosis, and much more.
With their understanding of TGF-beta biology and protein engineering, they can develop innovative treatment options to help the body grow and repair cells and muscles.
